» Articles » PMID: 12789571

The Gene for Stargardt Disease, ABCA4, is a Major Retinal Gene: a Mini-review

Overview
Publisher Informa Healthcare
Specialties Genetics
Ophthalmology
Date 2003 Jun 6
PMID 12789571
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

The gene ABCA4 encodes the rod and cone photoreceptor Rim protein, which is a transmembrane transporter of vitamin A intermediates. ABCA 4 mutations are responsible for a large variety of retinal degenerations including all cases of Stargardt macular dystrophy and fundus flavimaculatus, some forms of cone-rod degeneration, and retinitis pigmentosa, and likely increase the risk of developing age-related macular degeneration (AMD). The purpose of this mini-review is to highlight the advances in our understanding of Stargardt disease and the ABCA4 gene from the first description of the disease by Karl Stargardt in 1909 to gene discovery by Allikmets and colleagues in 1997. The knockout mouse model by Mata and co-workers has provided crucial pathophysiological information that has led to new ideas regarding treatment possibilities. These hypotheses were tested by Radu and colleagues in the mouse and shown to be efficacious.

Citing Articles

Advancing Insights into Pediatric Macular Diseases: A Comprehensive Review.

Ambrosio L, Perepelkina T, Elhusseiny A, Fulton A, Gonzalez Monroy J J Clin Med. 2025; 14(2).

PMID: 39860622 PMC: 11765775. DOI: 10.3390/jcm14020614.


Current developments of gene therapy in human diseases.

Liu F, Li R, Zhu Z, Yang Y, Lu F MedComm (2020). 2024; 5(9):e645.

PMID: 39156766 PMC: 11329757. DOI: 10.1002/mco2.645.


CRISPR-Cas9 in hiPSCs: A new era in personalized treatment for Stargardt disease.

Kuntam S, Cingaram P Mol Ther Nucleic Acids. 2023; 32:896-897.

PMID: 37273783 PMC: 10236169. DOI: 10.1016/j.omtn.2023.05.008.


Structural and Pathogenic Impacts of Variants in Retinal Degenerations-An In-Silico Study.

Cevik S, Biswas S, Biswas-Fiss E Int J Mol Sci. 2023; 24(8).

PMID: 37108442 PMC: 10138569. DOI: 10.3390/ijms24087280.


Efficient correction of variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients.

Siles L, Ruiz-Nogales S, Navines-Ferrer A, Mendez-Vendrell P, Pomares E Mol Ther Nucleic Acids. 2023; 32:64-79.

PMID: 36969552 PMC: 10034418. DOI: 10.1016/j.omtn.2023.02.032.